Cargando…

DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling

As angiogenesis is required for tumor growth and metastasis, suppressing angiogenesis is a promising strategy in limiting tumor progression. Vascular endothelial growth factor (VEGF)-A, a critical pro-angiogenic factor, has thus become an attractive target for therapeutic interventions in cancer. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shiu-Wen, Lien, Jin-Cherng, Kuo, Sheng-Chu, Huang, Tur-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325351/ https://www.ncbi.nlm.nih.gov/pubmed/27517319 http://dx.doi.org/10.18632/oncotarget.11152

Ejemplares similares

Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound
por: Hsu, Ming-Jen, et al.
Publicado: (2022)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway
por: Zhang, Pan, et al.
Publicado: (2023)

Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling
por: Chen, Hsiu-Mei, et al.
Publicado: (2015)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Inhibition of VEGF(165)/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis
por: Chen, Chi-Kuan, et al.
Publicado: (2016)

Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling
por: Wittig, Christine, et al.
Publicado: (2015)

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2020)

Beta IV spectrin inhibits the metastatic growth of melanoma by suppressing VEGFR2‐driven tumor angiogenesis
por: Kwak, Eun‐A., et al.
Publicado: (2023)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Displacement of a DNA binding protein by Dda helicase
por: Byrd, Alicia K., et al.
Publicado: (2006)

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014)

DDA-SKF: Predicting Drug–Disease Associations Using Similarity Kernel Fusion
por: Gao, Chu-Qiao, et al.
Publicado: (2022)

E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways
por: Huang, Tsung-Teng, et al.
Publicado: (2023)

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-mediated MAP kinase
por: Bansode, Rishipal R, et al.
Publicado: (2013)

Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling
por: Zhou, Xunian, et al.
Publicado: (2016)

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway
por: Zhang, Pan, et al.
Publicado: (2021)

2D Dynamic Directional Amplification (DDA) in Phononic Metamaterials
por: Kalderon, Moris, et al.
Publicado: (2021)

4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models
por: Huang, Tur-Fu, et al.
Publicado: (2022)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)
por: Oladipupo, Sunday S., et al.
Publicado: (2018)

VEGFR1 signaling in retinal angiogenesis and microinflammation
por: Uemura, Akiyoshi, et al.
Publicado: (2021)

MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
por: Ghosh, Alip, et al.
Publicado: (2017)

Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway
por: Tang, Ning, et al.
Publicado: (2015)

Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
por: Li, Xiao, et al.
Publicado: (2022)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide
por: Du, Jing-Jing, et al.
Publicado: (2022)

voomDDA: discovery of diagnostic biomarkers and classification of RNA-seq data
por: Zararsiz, Gokmen, et al.
Publicado: (2017)

Predicting chromosomal compartments directly from the nucleotide sequence with DNA-DDA
por: Lainscsek, Xenia, et al.
Publicado: (2023)

Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
por: Jin, Fa, et al.
Publicado: (2019)

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
por: Zhang, Qi, et al.
Publicado: (2019)

Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2021)

Coral-Derived Compound WA-25 Inhibits Angiogenesis by Attenuating the VEGF/VEGFR2 Signaling Pathway
por: Lin, Shih-Wei, et al.
Publicado: (2015)

Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo
por: Fang, Yan, et al.
Publicado: (2022)

The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression
por: Park, Mi Sun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3vsf81ngjk60b8oeq4t9e4fmlk